Receptor-independent low density lipoprotein (LDL) transport plays a critical role in the regulation of plasma cholesterol levels; hence, these studies were done to characterize this process in the tissues of the rat. High rates of receptor-independent clearance were found in the spleen, but other organs, like liver, gastrointestinal tract, and endocrine glands manifested lower clearance rates that varied from 3 to 9 Ml/h per g, while the rates in nervous tissue, muscle, and adipose tissue were <1 ;il/h per g.
Introduction
It is now recognized that low density lipoprotein (LDL)' is removed from the plasma by at least two distinct mechanisms that 1. Abbreviations used in this paper: hLDL, human low density lipoprotein; methyl-hLDL, human LDL that has been reductively methylated; methylrLDL, rat LDL that has been reductively methylated; rLDL, rat LDL; rSA, rat serum albumin.
are generally described as receptor dependent and receptor independent. Despite marked variations in cholesterol turnover in different animal species (1, 2) , the receptor-independent component plays an important and quantitatively similar role in the degradation of LDL in all animal species that have been examined, including the rat (25-43%) (3, 4) , hamster (29%) (4), rabbit (24-38%) (5, 6) , and guinea pig (21-22%) (7) , as well as in man (20-33%) (8, 9) . Furthermore, in animals or human subjects that lack LDL receptor activity, either because of an inherited defect in receptor synthesis (10, I 1) or because of dietary suppression of receptor activity (12) , this receptor-independent pathway must account for essentially all LDL turnover.
A limited number of studies are available, which suggests that nearly all organs in the body are capable of at least some degree of receptor-independent LDL uptake (6, 13, 14) . Unfortunately, these studies have often yielded conflicting data with respect to the quantitative importance of this process because ofthe manner in which the measurements were made, or because of the use of heterologous LDL preparations or the use of in vitro cell systems. Thus, while the cell biology and physiology of receptor-dependent LDL turnover are understood in considerable detail (15, 16) , there is relatively little quantitative data on the nature of receptor-independent LDL transport. Because of the potential importance of this process, the current studies were undertaken using a primed-continuous infusion technique to (a) quantitate the importance of receptor-independent LDL transport in the whole animal and in individual tissues of the rat; (b) define the kinetics of this uptake process; (c) examine possible mechanisms of regulation of receptor-independent transport; and (d) determine ifcholesterol taken up by this pathway exerts the same metabolic effects as LDL taken up by the receptor-dependent pathway.
Methods Animal preparation. Female Sprague Dawley-derived rats (CD [SD]BR,
Charles River Breeding Laboratories, Inc., Wilmington, MA), purchased in the weight range of 125-150 g, were housed in an isolated room with alternating 12-h periods of light (1500-0300 h) and darkness (0300-1500 h), and were allowed free access to water and rodent diet (Wayne Laboratory Animal Diets, Allied Mills, Inc., Chicago, IL) for at least 2 wk before being used. In one experiment, groups of animals were fed either 3% (wt/wt) cholestyramine or 0.5% (wt/wt) cholesterol for 7 d before being used.
Lipoprotein preparations. Plasma was obtained from normal human subjects fasted overnight and from rats (groups of 25-300, depending upon the experiment) that had been maintained on the low-cholesterol rodent diet. Both rat LDL (rLDL) and human LDL (hLDL) were harvested in the density range of 1.020-1.055 g/ml, and purified as previously described (3, 14) . On polyacrylamide gels, both LDL preparations contained essentially only apolipoprotein B1,0. The rLDL and hLDL, as well as rat serum albumin (rSA) (Miles Laboratory, Inc., Elkhart, IN),
were then labeled with either 25I (17) or ['4Cjsucrose ( 18) . In some cases, a portion ofthe radiolabeled rLDL and hLDL was reductively methylated (methyl-rLDL and methyl-hLDL) (19) , which, by direct analysis, modified 77-88% of the free amino groups (20) . All labeled lipoproteins were used within 12-24 h of preparation, and were passed through 0.45-,Om
Millipore filters just before being administered to the experimental animals.
Determination ofwhole-animal clearance rates. Whole-animal clearance (turnover) rates of the various lipoprotein preparations were measured using a constant infusion technique as previously described (3, 4 As illustrated diagrammatically in Fig. 1 , these values for tissue spaces were used to calculate two sets of data. In many tissues of animals killed at 10 min, the tissue space of LDL was much higher than the tissue space achieved by rSA (Fig. 1 A) . The difference in the two tissue spaces has been designated as the specific tissue space for that LDL preparation in that particular organ, and has the units of microliters per gram. Such specific tissue spaces have been shown to be saturable and regulable, and are essentially reduced to zero by reductive methylation ofthe lipoprotein (3, 21) and so were used in the present study as a measure of specific LDL binding to LDL transport sites.
In addition, rates of LDL transport were measured directly. As also shown in Fig. I A, was, in fact, the case for LDL that was taken up into various tissues by either predominantly receptor-mediated (rLDL) or receptor-independent (methyl-hLDL) mechanisms. As shown in Table I , regardless of the mechanism of uptake, only -2-6% of the '4C was lost from the tissues over a 6-h interval. The single exception was the intestine which, because of its high cell turnover, lost significantly greater amounts of the radioactive label. Determination of rates of cholesterol synthesis. In two studies, rates of cholesterol synthesis were measured in the livers of animals that had also been infused with ['4C]sucrose-LDL for measurement of lipoprotein clearance rates. At the completion of the infusions, aliquots of liver were taken and incubated in vitro with [3H]water (1, 22, 23) , and the rates of sterol synthesis were expressed as the nanomole of this precursor incorporated into digitonin precipitable sterols per hour per gram of tissue (nanomole per hour per gram).
Calculations. In most cases, data are presented as mean values±I SEM. Clearance rates were determined by using the least-squares method to fit linear regression curves to the data describing the change in tissue space as a function of time (see Fig. 1 ), and are presented as mean values± 1 SE.
Results
These studies were designed to provide quantitative data on the characteristics of receptor-independent LDL transport, and to compare the characteristics of this transport process with those ofthe receptor-dependent system. Two sets ofpreliminary studies were necessary, however, in order to establish that, in general, [ [14C] sucroserLDL to receptors in the liver (Fig. 3) , and the slightly lower whole-animal clearance rate ofthis same LDL preparation. Since the liver is the most important organ in determining LDL turnover, the lower clearance rate ofthe ['4C]sucrose-rLDL presumably reflects the slightly lower level of hepatic LDL binding of this '4C-labeled molecule.
Use of methyl-hLDL for measuring receptor-independent transport. The next study was undertaken to select the most suitable molecule for measuring rates of receptor-independent LDL transport. Previous work using rat fibroblasts (25) and the intact animal (3, 19, 26) has shown that both heterologous LDL and methyl-rLDL interact poorly with the LDL receptor in the rat. Thus, quantitative data were next obtained in vivo on the ability of four different ['4C]sucrose-labeled LDL preparations to specifically bind to the liver and to be cleared from the plasma space. As summarized in Table III , rLDL manifested a high degree oftissue binding and was rapidly cleared from the plasma at a rate of 695 gl/h per 100 g. Reductive methylation of the rLDL markedly reduced, but did not abolish, the tissue binding and whole-animal clearance. Human LDL also bound poorly to the liver, and was cleared from the plasma at a rate of 240 pl/h per 100 g. However, methylated hLDL manifested no specific tissue binding, i.e., the tissue spaces attained by methylhLDL and rSA were essentially equal, and was cleared from the plasma at the minimal rate of 186 pl/h per 100 g. Note that in rabbits lacking LDL receptors, i.e., the WHHL rabbit, the rate of homologous LDL and methyl-hLDL transport into tissues was essentially equal (unreported observation from this laboratory). Thus, taken together, all of these observations indicate that methyl-hLDL is taken up into tissues by mechanisms that do not depend upon the LDL receptor, and, therefore, this molecule is ideally suited for exploring the kinetics and metabolic consequences of receptor-independent LDL transport.
Rates ofreceptor-independent LDL transport in control rats. Having chosen methyl-hLDL as the probe for receptor-independent LDL transport, the next group ofstudies was undertaken to measure the rates of both total LDL uptake (rLDL) and receptor-independent LDL uptake (methyl-hLDL) in the various tissues of control rats fed a low-cholesterol diet. As shown in Table IV , the highest rates ofrLDL uptake in this species (Table   IV gl/h per g.
From the difference between total and receptor-independent LDL uptake, rates of receptor-dependent LDL transport could be calculated from these values and are expressed as a percentage of total LDL uptake in Table IV , column 3. The receptor-dependent component accounted for the majority ofthe high rates of LDL uptake observed in organs like the endocrine glands and Column I shows the rate of total LDL uptake (receptor dependent and receptor independent), while column 2 gives the rate of receptor-independent uptake. In a parallel experiment, a group of rats was also prepared with indwelling catheters in the bladder and common bile duct, and then they were infused with the two LDL preparations. (Table IV) and the weights of individual organs, it was next possible to determine the importance ofeach major organ to receptor-dependent and receptor-independent LDL degradation in the whole animal. As summarized in Table  V , the liver and small bowel accounted for 53 and 9.7%, respectively, of total LDL turnover in these rats, while degradation in each of the other organs was quantitatively small (Table V, (Table V, column 5 ). In contrast, of the 479 ,l of plasma cleared of its LDL content by the receptor-dependent mechanism, fully 67% took place in the liver alone. Except for the small intestine (7%), receptor-dependent LDL transport was quantitatively unimportant in the other organs. As an aside, it should also be noted that the sum of the clearance rates found in all ofthe organs listed in Table V equaled 88% of the clearance rates measured simultaneously in whole animals, and, furthermore, the degradation and loss of the I'4C]sucrose label in urine and bile equaled only 5.8% of the whole-animal clearance rate during the period of observation (Table V, column 3) . Kinetic characteristics ofreceptor-independent LDL transport. While these data provided information on the relative importance of receptor-independent LDL transport in the liver and other organs, they applied only to the rat with normal circulating LDL-cholesterol levels. In the next experiment, the hepatic clearance rates were measured, under circumstances where the plasma concentration of methyl-hLDL was abruptly increased to a new value, and then maintained at that value using the primed-continuous infusion technique. As shown in Fig. 5 A, under these conditions, receptor-independent LDL clearance by the liver remained constant at 7-9 u1/h per g, as the plasma LDL-cholesterol level was raised from -10 mg/dl to nearly 250 mg/dl. Thus, as shown in Fig. 5 B, the delivery of cholesterol into the liver by this mechanism was increased from -1 ,ug/h per g to nearly 20 ug/h per g. In animals with normal plasma LDL-cholesterol concentrations, -9 ug of LDL-cholesterol was taken up per hour per gram of liver (Fig. 5 B) and this rate is achieved because of the high, receptor-mediated clearance rate (Fig. 5 A) The values in columns 2 and 4 equal the product of the clearance rate for rLDL and methyl-hLDL shown in Table IV (td/h per g) and the mean whole organ weight (per 100 g animal, column 1), and are expressed as the microliter of plasma cleared of its LDL content per hour by each whole organ, per 100 g body weight. In columns 3 and 5 the clearance of rLDL and methyl-hLDL by each whole organ is expressed as a percentage of the corresponding whole-animal clearance rate. The whole-animal clearance rates were measured in separate groups of animals the same day, and equaled 659 Ml/h per 100 g body weight and 180 Ml/h per 100 g body weight for rLDL and methyl-hLDL, respectively.
that in the absence of LDL receptors, just as much, or more, LDL cholesterol could be taken up by the liver using the receptorindependent pathway, provided that the plasma LDL-cholesterol concentration was elevated to sufficiently high levels. Regulation of receptor-independent LDL transport. While alterations in cellular cholesterol content are known to effect receptor-dependent LDL transport (4, 10, 14) , little information is available on the effect of such manipulations on receptorindependent transport. Hence, rates of hepatic cholesterol synthesis were varied by either cholestyramine or cholesterol feeding, and receptor-independent LDL clearance was measured. As summarized in Table VI , the clearance of methyl-hLDL was constant at -7-9 ul/h per g under circumstances where the rate of hepatic sterol synthesis was varied from 89 to 1,007 nmol/h per g. Thus, hepatic receptor-independent LDL clearance remained constant not only under circumstances where the plasma LDL concentration was varied, but also where the rates of hepatic sterol synthesis were varied.
Regulatory effects of receptor-independent LDL-cholesterol uptake. A final group of studies was done to determine if LDLcholesterol taken up by receptor-independent LDL transport was equally effective in regulating cellular cholesterol synthesis as that taken up by the receptor-dependent process. Using the primed-continuous infusion technique, varying amounts of LDL-cholesterol, carried in either rLDL or methyl-hLDL, were delivered to the liver over a 14-h period. As shown in Fig. 6 A, after 14 h of infusion, the cumulative hepatic clearance of rLDL equaled -1,260 til/g, while that of methyl-hLDL averaged 120 ,gl/g. Thus, even over this prolonged period of infusion, the hourly clearance rates of rLDL (92% receptor dependent) and methyl-hLDL (100% receptor independent) remained essentially linear with respect to time, and equaled '-90 gl/h per g and 9 ,gl/h per g, respectively. From these cumulative clearance data, the mass of LDL-cholesterol taken up by the liver over the 14-h infusion period was calculated and is shown in Fig. 6 B.
From these data, it was apparent that -350 ,ug of LDLcholesterol could be delivered to each gram of liver by elevating Table VII . In this experiment, as shown in Table  VII , column 1, essentially equal amounts of LDL-cholesterol were taken up by the liver, as determined directly by the uptake of the ['4C]sucrose marker, and this resulted in a similar degree of suppression of the rate of hepatic cholesterol synthesis (Table  VII, column 2) . Furthermore, the content of cholesteryl esters increased 66 and 140% in the animals infused with rLDL and methyl-hLDL, respectively. Thus, when nearly equal amounts of sterol were taken up by either the receptor-dependent or receptor-independent pathway, there was significant suppression of de novo cholesterol synthesis and a rise in the level of hepatic cholesteryl esters.
Discussion
Receptor-independent LDL degradation accounts for the turnover of -20-40% ofthe circulating LDL pool in normal animals and man (3) (4) (5) (6) (7) (8) (9) , and for essentially 100% ofthe pool in the rabbit and human lacking LDL receptors (5, 10). As shown in the present studies, nearly every tissue in the body manifests at least some level of receptor-independent LDL transport, which, like receptor-dependent LDL uptake, contributes cholesterol to the intracellular pools and leads to feedback regulation of the rate of cholesterol synthesis. Thus, most organs can potentially acquire sterol from at least three different sources including de novo cholesterol synthesis within the cell and the receptor-dependent and receptor-independent uptake of LDL-cholesterol. While the interaction of these three processes are remarkably effective in maintaining sterol balance across individual organs under even pathological conditions, this balance is often achieved at the expense of potentially harmful shifts in the concentration of LDL in the circulating plasma. (5) 353±22 124±21 Methyl-hLDL infused (6) 381±22 154±16
As described in the legend to Fig. 6 , these animals were infused with either rLDL (a bolus of 2.5 mg followed by 0.5 mg of LDL-cholesterol per hour) or methyl-hLDL (a bolus of 40 mg followed by 1.7 mg of LDL-cholesterol per hour) for 14 h. At the end of this time, the animals were killed and the content of '4C in each liver was determined.
From this value, and the specific activity of the ['4C]sucrose-LDL preparation infused (dpm per microgram of LDL cholesterol), the amount of cholesterol taken up by the liver from the two LDL preparations was calculated (column 1). Aliquots of these same livers were also assayed for rates of cholesterol synthesis in vitro (column 2).
Mean values± 1 SEM for the number of animals shown in parentheses are given.
Because of the importance of the interaction of these three processes, the present studies were undertaken to provide detailed, quantitative data on the characteristics of receptor-independent LDL transport in the whole animal and in individual organs of the rat. There are three technical features of these studies that should be emphasized. First, homologous, purified LDL (rLDL) was used to measure rates of total LDL clearance in the whole animal and in individual organs. It is now recognized that serious quantitative errors in assessing the importance of receptor-independent LDL transport in vivo and in isolated cells have resulted from measuring total LDL clearance with heterologous lipoprotein preparations, which interact poorly with the LDL receptor. Second, at least in the rat, reductive methylation alone does not totally abolish interaction of rLDL with the LDL receptor (Table III) . However, reductive methylation of heterologous LDL (methyl-hLDL) does eliminate all specific binding and reduces whole-animal turnover to a minimal value. Thus, methyl-hLDL was used to quantitate receptor-independent LDL transport in these studies. Third, uptake rates were measured using LDL preparations labeled with ["'C]sucrose, which is retained by the tissues for fairly long periods of time after uptake of the LDL molecule (13, 18) . Such ['"Clsucrose-labeled LDL behaves nearly identically with '25I-labeled lipoprotein (Table  II, and Figs. [2] [3] [4] . By using such labeled preparations with the primed-continuous infusion technique, it was possible to measure absolute rates of tissue clearance under circumstances where the rate of tissue uptake was linear with respect to time and independent of plasma levels of radioactivity, and at sufficiently short intervals to minimize differences in rates of tissue degradation and loss of the "'C-label (Table I ). Note that, using this technique, the sum of the rates of clearance of the various LDL preparations by all major organs in the body essentially equalled the rate of whole-animal turnover (Table V and reference 14) .
From the data derived using this technique, a number of important conclusions can be drawn with respect to both receptor-independent and receptor-dependent LDL transport in the various organs of the rat. As in the hamster (14), the rates of total LDL clearance by the various organs varied over a 200-fold range when expressed per gram of tissue. The highest rates were found in the endocrine glands, liver, spleen, kidney, and small intestine, while very low rates were encountered in adipose tissue, skin, and skeletal muscle (Table IV) . The receptor-independent component of this uptake process was high in spleen, but much lower in most other organs. As a consequence of these differences it is apparent that in nearly all of those organs that manifested rapid LDL uptake, the high rates of clearance were achieved through the presence of large amounts of LDL receptor activity. Thus, receptor-dependent LDL uptake accounted for most of the total LDL uptake observed in the adrenal gland (99%), ovary (95%), liver (92%), kidney (83%), and lung (8 1%). The two exceptions were the small intestine (56%) and spleen (31%), both of which had large components of receptor-independent uptake. In all other tissues in the body, rates of LDL uptake were very low, and no receptor-dependent component could be identified (Table IV ). Note that previous reports which suggested that receptor-independent transport was quantitatively much more important in organs like liver (13, 27) were probably the result of using heterologous LDL preparations that grossly underestimated the receptor-dependent component.
More importantly, these data can also be viewed in terms of the role of each of the whole organs in receptor-dependent and receptor-independent LDL degradation. In the normal rat, for example, receptor-dependent LDL clearance in the whole animal equalled -479 ,l/h per 100 g body weight, and most of this activity was found in the liver (67%) and small intestine (8%). Furthermore; the value in this latter tissue may have been significantly underestimated because of more rapid loss of the '4C-label from the intestinal epithelial cells (Table 1) . Receptordependent LDL uptake in the remaining organs was quantitatively oflittle importance. In contrast, receptor-independent LDL clearance in the whole animal equaled 180 gl/h per 100 g body weight, and this activity was distributed in a number of organs including skeletal muscle (20%), liver (16%), small intestine (15%), skin (10%), spleen (7%), and adipose tissue (6%). Thus, the observation that the liver is the major organ for LDL removal from the plasma in the normal rat (53%), hamster (73%) (14), and, probably, man (1 1), is due to the fact that the liver contains most of the receptor-dependent transport activity found in the whole body.
However, these quantitative relations apply only to the experimental animal and to man wheh the circulating LDL-cholesterol concentration is normal. Since receptor-mediated LOL clearance involves interaction with a finite number of binding sites on the cell surface ( 15), receptor-mediated transport in organs like the liver manifests saturation kinetics (12, 14) . As demonstrated in these studies, the rate ofreceptor-independent LDL uptake is a linear function of plasma LDL concentration, so that the rate of clearance by this mechanism is constant over a very large range of plasma lipoprotein concentrations (Figs. 5 and 6). Thus, when the plasma LDL-cholesterol concentration is raised, e.g., by increasing LDL production, it necessarily follows that the receptor-independent component of transport becomes quantitatively more important in every organ, as well as in the A question ofcritical importance, however, is whether LDLcholesterol taken up into the liver and other tissues by the receptor-independent pathway enters into the same intracellular pools as sterol transported via the LDL receptor, and whether it is capable of being a substrate for the esterification reaction and of acting as a regulator ofthe rate ofintracellular cholesterol synthesis. Although earlier studies suggested that cholesterol taken up by receptor-independent means might not exert metabolic regulation (reviewed in reference 28), several lines of evidence suggest that this conclusion is not warranted, at least in vivo. In liver, for example, as much LDL-choiesterol could be delivered to the hepatocytes by the receptor-independent pathway as by the receptor-dependent system, although much higher plasma LDL levels were required (Fig. 6 ). Under these circumstances, there was comparable suppression of cholesterol synthesis and elevation in the levels ofcholesteryl esters (Table VII) . In other studies, the infusion of large amounts of hLDL, which in the rat is taken up predominately by the receptor-independent pathway, clearly inhibited cholesterol synthesis and raised the (29) , and suppressed the rates of sterol synthesis in most extrahepatic organs (30) . Furthermore, in the rabbit lacking LDL receptor activity, the rates of cholesterol synthesis in nearly all of the organs in the body essentially equalled the rates found in the normal animal (31) . Thus, LDL-cholesterol taken up by the receptor-independent pathway can regulate intracellular metabolism. Finally, the receptor-independent LDL uptake quantitated in the various organs in this study presumably reflected the presence of this transport process in the parenchymal cells of each of these tissues rather than uptake in a second set of cells, such as the vascular endothelium or tissue macrophages or fibroblasts.
In the intestine and liver, at least, an essentially identical pattern of receptor-independent and receptor-dependent LDL uptake was found after isolation and partial purification ofthe respective parenchymal cells (6, 32; and D. K. Spady and J. M. Dietschy, unpublished observations), as was found in the whole organs (Table IV) . The kinetics of this process, its lack of regulability and the fact that the clearance rates of albumin and methylhLDL were similar in most tissues, suggests that receptor-independent LDL transport may be mediated by a mechanism like fluid endocytosis. The occasional differences seen in the uptake rates of the different probe molecules could easily be explained by differences in the sieving effects of the endothelial diffusion barriers, or by charge or nonsolvent water effects within the endocytotic vesicles. Nevertheless, it is clear that the molecular mechanisms responsible for receptor-independent LDL transport require further work.
Thus, these studies demonstrate that nearly every organ in the body is capable of taking up LDL-cholesterol by receptorindependent mechanisms. In the normal animal and man, however, most LDL-cholesterol is removed from the plasma by receptor-mediated transport mechanisms that are located primarily in the liver and intestine, so that the cholesterol can be readily excreted from the body. If the LDL receptors are absent or lost with aging or the intake ofdietary cholesterol and saturated fatty acids, receptor-independent LDL transport becomes quantitatively much more important, and is capable of maintaining sterol balance across the individual tissues as well as the whole animal. However, in order to achieve the rates of LDL transport via the receptor-independent mechanism that are necessary to maintain this balance, the plasma LDL-cholesterol levels must necessarily rise.
